Doctors test shorter, stronger radiation blast for breast tumors
NCT ID NCT00872625
Summary
This early-stage study tested a new approach for treating breast cancer before surgery. It combined a shorter, more intense course of targeted radiation (CyberKnife) with chemotherapy drugs. The main goal was to find the safest and most effective radiation dose to shrink tumors, with the hope of allowing more women to have breast-conserving surgery instead of a full mastectomy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.